| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.25e-05 | 2 | 71 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.25e-05 | 2 | 71 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.73e-05 | 3 | 71 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor 1 binding | 7.44e-05 | 4 | 71 | 2 | GO:0051430 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor binding | 1.85e-04 | 6 | 71 | 2 | GO:0051429 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 1.85e-04 | 6 | 71 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.50e-04 | 86 | 71 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 3.07e-04 | 37 | 71 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 4.42e-04 | 9 | 71 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 YTHDF1 TCF4 KMT2D MAK SNAP91 ATF7IP IRS1 WNK1 CREBBP EP300 YTHDF3 | 7.40e-04 | 1160 | 71 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 8.04e-04 | 12 | 71 | 2 | GO:0008140 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 8.40e-04 | 52 | 71 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 YTHDF1 TCF4 KMT2D MAK SNAP91 ATF7IP GLIPR1L1 IRS1 WNK1 CREBBP EP300 YTHDF3 | 8.86e-04 | 1356 | 71 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 9.38e-04 | 54 | 71 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.05e-03 | 582 | 71 | 8 | GO:0140297 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.19e-03 | 739 | 71 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.27e-03 | 15 | 71 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.27e-03 | 15 | 71 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.68e-03 | 66 | 71 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.68e-03 | 66 | 71 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor binding | 1.84e-03 | 18 | 71 | 2 | GO:0005159 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.27e-03 | 20 | 71 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peptide hormone receptor binding | 2.51e-03 | 21 | 71 | 2 | GO:0051428 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.51e-03 | 21 | 71 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.01e-03 | 23 | 71 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 3.27e-03 | 24 | 71 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.78e-03 | 562 | 71 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 4.13e-03 | 27 | 71 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.48e-03 | 303 | 71 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA2 SOX11 TCF4 POU6F2 BARHL2 ZFHX3 RFX7 ZNF853 CREBBP MNT TFAP4 EP300 | 5.05e-03 | 1459 | 71 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | 5.16e-03 | 753 | 71 | 8 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 SOX11 TCF4 CRTC3 KMT2D BARHL2 MED25 ITGA8 AUTS2 ZFHX3 TAF4 MLLT10 RFX7 CREBBP CCNK TFAP4 EP300 | 3.51e-06 | 1390 | 71 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 6.98e-05 | 4 | 71 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 6.98e-05 | 4 | 71 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | cognition | 1.01e-04 | 423 | 71 | 8 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.34e-04 | 29 | 71 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.74e-04 | 239 | 71 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.74e-04 | 151 | 71 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 1.74e-04 | 6 | 71 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | behavior | NCOA2 YTHDF1 CACNA1E SLITRK5 ITGA8 AUTS2 ZFHX3 SYNPO CREBBP CRH EP300 | 2.19e-04 | 891 | 71 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 2.36e-04 | 35 | 71 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 2.36e-04 | 35 | 71 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | regulation of somatostatin secretion | 2.43e-04 | 7 | 71 | 2 | GO:0090273 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOA2 SOX11 TRIM66 FLNA TCF4 SCAF8 ATF7IP MED25 ZFHX3 CREBBP ZNF282 MNT TFAP4 EP300 | 2.54e-04 | 1399 | 71 | 14 | GO:0045892 |
| GeneOntologyBiologicalProcess | stress granule assembly | 2.57e-04 | 36 | 71 | 3 | GO:0034063 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOA2 SOX11 TRIM66 FLNA TCF4 SCAF8 ATF7IP MED25 ZFHX3 CREBBP ZNF282 MNT TFAP4 EP300 | 2.82e-04 | 1413 | 71 | 14 | GO:1902679 |
| GeneOntologyBiologicalProcess | learning or memory | 2.94e-04 | 373 | 71 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | axon development | YTHDF1 FLNA SNAP91 BARHL2 SLITRK5 AUTS2 ARHGAP35 TFAP4 EP300 | 3.45e-04 | 642 | 71 | 9 | GO:0061564 |
| GeneOntologyBiologicalProcess | somatostatin secretion | 4.14e-04 | 9 | 71 | 2 | GO:0070253 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 FLNA TCF4 KMT2D SMG7 PNN SCAF8 DROSHA LIN54 MED25 TAF4 SAGE2P CREBBP CCNK CSTF2T MX2 | 1.17e-05 | 1377 | 71 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | 3.18e-05 | 596 | 71 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 SOX11 TRIM66 TCF4 POU6F2 TOX4 BARHL2 ADNP2 ZFHX3 TAF4 RFX7 CREBBP MNT TFAP4 EP300 | 1.10e-04 | 1480 | 71 | 15 | GO:0000785 |
| HumanPheno | Large foramen magnum | 2.34e-06 | 6 | 26 | 3 | HP:0002700 | |
| HumanPheno | Motor stereotypy | 5.50e-06 | 280 | 26 | 9 | HP:0000733 | |
| HumanPheno | Clinodactyly | SOX11 FLNA TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK EP300 | 8.13e-06 | 574 | 26 | 12 | HP:0030084 |
| HumanPheno | Broad distal phalanx of finger | 8.65e-06 | 27 | 26 | 4 | HP:0009836 | |
| HumanPheno | Abnormal size of the palpebral fissures | 9.18e-06 | 298 | 26 | 9 | HP:0200007 | |
| HumanPheno | Pilomatrixoma | 9.72e-06 | 9 | 26 | 3 | HP:0030434 | |
| HumanPheno | Abnormality of the fifth metatarsal bone | 9.72e-06 | 9 | 26 | 3 | HP:0008089 | |
| HumanPheno | Short columella | 1.16e-05 | 29 | 26 | 4 | HP:0002000 | |
| HumanPheno | Frontal hirsutism | 1.38e-05 | 10 | 26 | 3 | HP:0011335 | |
| HumanPheno | Abnormality of the philtrum | SOX11 FLNA TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 1.56e-05 | 726 | 26 | 13 | HP:0000288 |
| HumanPheno | Abnormality of dental eruption | 1.61e-05 | 240 | 26 | 8 | HP:0006292 | |
| HumanPheno | Frontal upsweep of hair | 1.97e-05 | 33 | 26 | 4 | HP:0002236 | |
| HumanPheno | Plantar crease between first and second toes | 2.51e-05 | 2 | 26 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.51e-05 | 2 | 26 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.51e-05 | 2 | 26 | 2 | HP:0001042 | |
| HumanPheno | Overlapping toe | 2.56e-05 | 72 | 26 | 5 | HP:0001845 | |
| HumanPheno | Short palpebral fissure | 2.59e-05 | 122 | 26 | 6 | HP:0012745 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 2.81e-05 | 36 | 26 | 4 | HP:0009617 | |
| HumanPheno | Abnormality of the palmar creases | 2.89e-05 | 260 | 26 | 8 | HP:0010490 | |
| HumanPheno | Deep philtrum | 3.13e-05 | 75 | 26 | 5 | HP:0002002 | |
| HumanPheno | Keloids | 3.26e-05 | 13 | 26 | 3 | HP:0010562 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 3.32e-05 | 265 | 26 | 8 | HP:0001018 | |
| HumanPheno | Natal tooth | 3.50e-05 | 38 | 26 | 4 | HP:0000695 | |
| HumanPheno | Abnormal external nose morphology | SOX11 FLNA TCF4 KMT2D MED25 ITGA8 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 3.78e-05 | 916 | 26 | 14 | HP:0010938 |
| HumanPheno | Anteverted nares | SOX11 TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK SEC23A | 4.16e-05 | 559 | 26 | 11 | HP:0000463 |
| HumanPheno | Upturned nose | SOX11 TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK SEC23A | 4.16e-05 | 559 | 26 | 11 | HP:0000427 |
| HumanPheno | Thick vermilion border | 4.82e-05 | 279 | 26 | 8 | HP:0012471 | |
| HumanPheno | Abnormality of upper lip vermillion | 4.96e-05 | 464 | 26 | 10 | HP:0011339 | |
| HumanPheno | Cafe-au-lait spot | 5.01e-05 | 137 | 26 | 6 | HP:0000957 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 5.03e-05 | 368 | 26 | 9 | HP:0031432 | |
| HumanPheno | Abnormal cheek morphology | 5.20e-05 | 282 | 26 | 8 | HP:0004426 | |
| HumanPheno | Abnormal hair whorl | 5.23e-05 | 42 | 26 | 4 | HP:0010721 | |
| HumanPheno | Abnormal nostril morphology | SOX11 TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK SEC23A | 5.42e-05 | 575 | 26 | 11 | HP:0005288 |
| HumanPheno | Neoplasm of the liver | 5.66e-05 | 140 | 26 | 6 | HP:0002896 | |
| HumanPheno | Perseverative thought | 6.09e-05 | 377 | 26 | 9 | HP:0030223 | |
| HumanPheno | Single transverse palmar crease | 7.17e-05 | 215 | 26 | 7 | HP:0000954 | |
| HumanPheno | Disordered formal thought process | 7.34e-05 | 386 | 26 | 9 | HP:0025769 | |
| HumanPheno | Abnormal nasal tip morphology | 7.34e-05 | 386 | 26 | 9 | HP:0000436 | |
| HumanPheno | Laryngeal cartilage malformation | 7.49e-05 | 3 | 26 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 7.49e-05 | 3 | 26 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 7.49e-05 | 3 | 26 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 7.49e-05 | 3 | 26 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 7.49e-05 | 3 | 26 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 7.49e-05 | 3 | 26 | 2 | HP:0005895 | |
| HumanPheno | Prominent fingertip pads | 7.53e-05 | 46 | 26 | 4 | HP:0001212 | |
| HumanPheno | Advanced eruption of teeth | 7.53e-05 | 46 | 26 | 4 | HP:0006288 | |
| HumanPheno | Premature thelarche | 7.66e-05 | 17 | 26 | 3 | HP:0010314 | |
| HumanPheno | Abnormal upper lip morphology | SOX11 FLNA TCF4 KMT2D MED25 ITGA8 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 8.27e-05 | 980 | 26 | 14 | HP:0000177 |
| HumanPheno | Delayed speech and language development | SOX11 CACNA1E FLNA TCF4 KMT2D MED25 AUTS2 TAF4 GNAS HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 8.29e-05 | 1123 | 26 | 15 | HP:0000750 |
| HumanPheno | Full cheeks | 8.65e-05 | 151 | 26 | 6 | HP:0000293 | |
| HumanPheno | Abnormal testis morphology | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 CREBBP EP300 SEC23A | 8.85e-05 | 1129 | 26 | 15 | HP:0000035 |
| HumanPheno | Prominent digit pad | 8.91e-05 | 48 | 26 | 4 | HP:0011298 | |
| HumanPheno | Non-obstructive azoospermia | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 CREBBP EP300 SEC23A | 9.14e-05 | 1132 | 26 | 15 | HP:0011961 |
| HumanPheno | Facial hirsutism | 9.16e-05 | 18 | 26 | 3 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 9.16e-05 | 18 | 26 | 3 | HP:0012842 | |
| HumanPheno | Abnormal thought pattern | 1.05e-04 | 404 | 26 | 9 | HP:5200269 | |
| HumanPheno | Wide nasal bridge | 1.08e-04 | 508 | 26 | 10 | HP:0000431 | |
| HumanPheno | Abnormal columella morphology | 1.08e-04 | 97 | 26 | 5 | HP:0009929 | |
| HumanPheno | Abnormal dermatoglyphics | 1.12e-04 | 314 | 26 | 8 | HP:0007477 | |
| HumanPheno | Azoospermia | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 CREBBP EP300 SEC23A | 1.19e-04 | 1157 | 26 | 15 | HP:0000027 |
| HumanPheno | Gastroesophageal reflux | 1.26e-04 | 517 | 26 | 10 | HP:0002020 | |
| HumanPheno | Irregular hyperpigmentation | 1.36e-04 | 238 | 26 | 7 | HP:0007400 | |
| HumanPheno | Abnormal male external genitalia morphology | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 RFX7 CREBBP EP300 SEC23A | 1.43e-04 | 1329 | 26 | 16 | HP:0000032 |
| HumanPheno | Abnormal morphology of the nasal alae | SOX11 TCF4 KMT2D MED25 AUTS2 TAF4 HUWE1 RFX7 CREBBP CCNK SEC23A | 1.44e-04 | 639 | 26 | 11 | HP:0000429 |
| HumanPheno | Localized hirsutism | 1.48e-04 | 21 | 26 | 3 | HP:0009889 | |
| HumanPheno | Language impairment | SOX11 CACNA1E FLNA TCF4 KMT2D MED25 AUTS2 TAF4 GNAS HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 1.48e-04 | 1178 | 26 | 15 | HP:0002463 |
| HumanPheno | Congenital abnormal hair pattern | 1.49e-04 | 327 | 26 | 8 | HP:0011361 | |
| HumanPheno | Trichiasis | 1.49e-04 | 4 | 26 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0410266 | |
| HumanPheno | Short 3rd metacarpal | 1.49e-04 | 4 | 26 | 2 | HP:0010041 | |
| HumanPheno | Talon cusp | 1.49e-04 | 4 | 26 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.49e-04 | 4 | 26 | 2 | HP:0006200 | |
| HumanPheno | Broad distal phalanx of the thumb | 1.49e-04 | 4 | 26 | 2 | HP:0009642 | |
| HumanPheno | Vascular ring | 1.49e-04 | 4 | 26 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0031207 | |
| HumanPheno | Abnormal ilium morphology | 1.51e-04 | 104 | 26 | 5 | HP:0002867 | |
| HumanPheno | Low hanging columella | 1.64e-04 | 56 | 26 | 4 | HP:0009765 | |
| HumanPheno | Abnormal spermatogenesis | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 CREBBP EP300 SEC23A | 1.68e-04 | 1190 | 26 | 15 | HP:0008669 |
| HumanPheno | Upslanted palpebral fissure | 1.69e-04 | 333 | 26 | 8 | HP:0000582 | |
| HumanPheno | Thin upper lip vermilion | 1.91e-04 | 339 | 26 | 8 | HP:0000219 | |
| HumanPheno | Thin lips | 1.91e-04 | 339 | 26 | 8 | HP:0000213 | |
| HumanPheno | Abnormal foramen magnum morphology | 1.95e-04 | 23 | 26 | 3 | HP:0002699 | |
| HumanPheno | Short philtrum | 2.00e-04 | 253 | 26 | 7 | HP:0000322 | |
| HumanPheno | Abnormal external genitalia | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 RFX7 CREBBP EP300 SEC23A | 2.15e-04 | 1372 | 26 | 16 | HP:0000811 |
| HumanPheno | Abnormal nasal septum morphology | 2.42e-04 | 115 | 26 | 5 | HP:0000419 | |
| HumanPheno | Short metatarsal | 2.43e-04 | 62 | 26 | 4 | HP:0010743 | |
| HumanPheno | Aplasia/Hypoplasia of the 3rd metacarpal | 2.48e-04 | 5 | 26 | 2 | HP:0010039 | |
| HumanPheno | Abnormal 3rd metacarpal morphology | 2.48e-04 | 5 | 26 | 2 | HP:0010011 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.48e-04 | 5 | 26 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.48e-04 | 5 | 26 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.48e-04 | 5 | 26 | 2 | HP:0030421 | |
| HumanPheno | macules | 2.49e-04 | 262 | 26 | 7 | HP:0200031 | |
| HumanPheno | Hypoplastic ilia | 2.59e-04 | 63 | 26 | 4 | HP:0000946 | |
| HumanPheno | Smooth philtrum | 2.65e-04 | 185 | 26 | 6 | HP:0000319 | |
| HumanPheno | Deviation of toes | 2.73e-04 | 118 | 26 | 5 | HP:0100498 | |
| HumanPheno | Abnormal male internal genitalia morphology | SOX11 FLNA TCF4 POU6F2 KMT2D MAK MED25 AUTS2 SEC31A TAF4 GNAS HUWE1 CREBBP EP300 SEC23A | 2.82e-04 | 1243 | 26 | 15 | HP:0000022 |
| HumanPheno | Toe clinodactyly | 2.84e-04 | 26 | 26 | 3 | HP:0001863 | |
| HumanPheno | Perimembranous ventricular septal defect | 2.84e-04 | 26 | 26 | 3 | HP:0011682 | |
| HumanPheno | Abnormal lip morphology | SOX11 FLNA TCF4 KMT2D MED25 ITGA8 AUTS2 SEC31A TAF4 HUWE1 RFX7 CREBBP CCNK EP300 SEC23A | 2.99e-04 | 1249 | 26 | 15 | HP:0000159 |
| HumanPheno | Aplasia/Hypoplasia of metatarsal bones | 3.10e-04 | 66 | 26 | 4 | HP:0001964 | |
| MousePheno | abnormal circulating glucagon level | 2.84e-05 | 40 | 62 | 4 | MP:0002695 | |
| Domain | Nuc_rcpt_coact | 1.04e-06 | 6 | 71 | 3 | IPR009110 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.42e-05 | 2 | 71 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.42e-05 | 2 | 71 | 2 | PF08214 | |
| Domain | KIX | 1.42e-05 | 2 | 71 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.42e-05 | 2 | 71 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.42e-05 | 2 | 71 | 2 | IPR031162 | |
| Domain | DUF902 | 1.42e-05 | 2 | 71 | 2 | PF06001 | |
| Domain | - | 1.42e-05 | 2 | 71 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.42e-05 | 2 | 71 | 2 | IPR010303 | |
| Domain | - | 1.42e-05 | 2 | 71 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.42e-05 | 2 | 71 | 2 | PF09030 | |
| Domain | - | 1.42e-05 | 2 | 71 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.42e-05 | 2 | 71 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.42e-05 | 2 | 71 | 2 | PS50134 | |
| Domain | RhoGAP-FF1 | 1.42e-05 | 2 | 71 | 2 | PF16512 | |
| Domain | RhoGAP-FF1 | 1.42e-05 | 2 | 71 | 2 | IPR032835 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.42e-05 | 2 | 71 | 2 | IPR013178 | |
| Domain | KAT11 | 1.42e-05 | 2 | 71 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.42e-05 | 2 | 71 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.42e-05 | 2 | 71 | 2 | IPR003101 | |
| Domain | KIX | 1.42e-05 | 2 | 71 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.42e-05 | 2 | 71 | 2 | PS51727 | |
| Domain | BAT2_N | 4.26e-05 | 3 | 71 | 2 | PF07001 | |
| Domain | BAT2_N | 4.26e-05 | 3 | 71 | 2 | IPR009738 | |
| Domain | PRRC2 | 4.26e-05 | 3 | 71 | 2 | IPR033184 | |
| Domain | YTH_domain | 1.41e-04 | 5 | 71 | 2 | IPR007275 | |
| Domain | YTH | 1.41e-04 | 5 | 71 | 2 | PS50882 | |
| Domain | YTH | 1.41e-04 | 5 | 71 | 2 | PF04146 | |
| Domain | FF | 2.12e-04 | 6 | 71 | 2 | PF01846 | |
| Domain | FF | 2.12e-04 | 6 | 71 | 2 | SM00441 | |
| Domain | FF_domain | 2.12e-04 | 6 | 71 | 2 | IPR002713 | |
| Domain | FF | 2.12e-04 | 6 | 71 | 2 | PS51676 | |
| Domain | BROMODOMAIN_1 | 3.73e-04 | 37 | 71 | 3 | PS00633 | |
| Domain | Bromodomain | 4.04e-04 | 38 | 71 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.06e-04 | 41 | 71 | 3 | PS50014 | |
| Domain | BROMO | 5.43e-04 | 42 | 71 | 3 | SM00297 | |
| Domain | Bromodomain | 5.43e-04 | 42 | 71 | 3 | IPR001487 | |
| Domain | - | 5.43e-04 | 42 | 71 | 3 | 1.20.920.10 | |
| Domain | - | 7.90e-04 | 109 | 71 | 4 | 4.10.280.10 | |
| Domain | HLH | 9.96e-04 | 116 | 71 | 4 | SM00353 | |
| Domain | BHLH | 1.03e-03 | 117 | 71 | 4 | PS50888 | |
| Domain | bHLH_dom | 1.06e-03 | 118 | 71 | 4 | IPR011598 | |
| Domain | HMG_box | 1.08e-03 | 53 | 71 | 3 | PF00505 | |
| Domain | HMG | 1.14e-03 | 54 | 71 | 3 | SM00398 | |
| Domain | - | 1.20e-03 | 55 | 71 | 3 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.94e-03 | 65 | 71 | 3 | IPR009071 | |
| Domain | ZZ | 2.10e-03 | 18 | 71 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.10e-03 | 18 | 71 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.10e-03 | 18 | 71 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.34e-03 | 19 | 71 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.34e-03 | 19 | 71 | 2 | SM00291 | |
| Domain | Znf_FYVE_PHD | 2.38e-03 | 147 | 71 | 4 | IPR011011 | |
| Domain | PHD | 2.92e-03 | 75 | 71 | 3 | PF00628 | |
| Domain | EPHD | 3.13e-03 | 22 | 71 | 2 | PS51805 | |
| Domain | Znf_PHD-finger | 3.39e-03 | 79 | 71 | 3 | IPR019787 | |
| Domain | Bromodomain_CS | 4.37e-03 | 26 | 71 | 2 | IPR018359 | |
| Domain | - | 4.37e-03 | 26 | 71 | 2 | 1.25.40.90 | |
| Domain | PHD | 4.73e-03 | 89 | 71 | 3 | SM00249 | |
| Domain | Znf_PHD | 5.04e-03 | 91 | 71 | 3 | IPR001965 | |
| Domain | ZnF_U1 | 5.41e-03 | 29 | 71 | 2 | SM00451 | |
| Domain | Znf_U1 | 5.41e-03 | 29 | 71 | 2 | IPR003604 | |
| Domain | ENTH_VHS | 5.41e-03 | 29 | 71 | 2 | IPR008942 | |
| Domain | ZF_PHD_2 | 5.68e-03 | 95 | 71 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 5.84e-03 | 96 | 71 | 3 | PS01359 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.85e-05 | 49 | 51 | 4 | M41832 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.50e-05 | 18 | 51 | 3 | M26942 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.17e-04 | 70 | 51 | 4 | M938 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.27e-04 | 5 | 51 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.27e-04 | 5 | 51 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.27e-04 | 5 | 51 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.27e-04 | 5 | 51 | 2 | M27228 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.69e-04 | 30 | 51 | 3 | M207 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.91e-04 | 6 | 51 | 2 | M22062 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.37e-04 | 84 | 51 | 4 | M1008 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.47e-04 | 34 | 51 | 3 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 2.47e-04 | 34 | 51 | 3 | M44 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.66e-04 | 7 | 51 | 2 | MM1573 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.22e-04 | 91 | 51 | 4 | M27101 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.22e-04 | 91 | 51 | 4 | M39700 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 3.36e-04 | 92 | 51 | 4 | M39441 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.54e-04 | 8 | 51 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.54e-04 | 8 | 51 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.54e-04 | 8 | 51 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.54e-04 | 8 | 51 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.55e-04 | 9 | 51 | 2 | M47451 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.32e-04 | 44 | 51 | 3 | M27295 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.67e-04 | 10 | 51 | 2 | M27945 | |
| Pathway | REACTOME_ADIPOGENESIS | 6.61e-04 | 110 | 51 | 4 | M48259 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.91e-04 | 11 | 51 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.91e-04 | 11 | 51 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.91e-04 | 11 | 51 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.28e-04 | 12 | 51 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.28e-04 | 12 | 51 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION | 8.28e-04 | 12 | 51 | 2 | M47770 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 8.61e-04 | 118 | 51 | 4 | M27316 | |
| Pathway | PID_AR_TF_PATHWAY | 9.20e-04 | 53 | 51 | 3 | M151 | |
| Pathway | WP_IL4_SIGNALING | 9.72e-04 | 54 | 51 | 3 | M39720 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.03e-03 | 55 | 51 | 3 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.03e-03 | 55 | 51 | 3 | M27001 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.14e-03 | 14 | 51 | 2 | M27808 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.26e-03 | 59 | 51 | 3 | M261 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.31e-03 | 15 | 51 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.31e-03 | 15 | 51 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.31e-03 | 15 | 51 | 2 | MM1439 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27 | 1.31e-03 | 15 | 51 | 2 | M47973 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.31e-03 | 15 | 51 | 2 | M953 | |
| Pathway | PID_AR_PATHWAY | 1.38e-03 | 61 | 51 | 3 | M58 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.49e-03 | 16 | 51 | 2 | M27121 | |
| Pathway | REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS | 1.49e-03 | 16 | 51 | 2 | M26971 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.49e-03 | 16 | 51 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.49e-03 | 16 | 51 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.49e-03 | 16 | 51 | 2 | M8516 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.49e-03 | 16 | 51 | 2 | MM15605 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.49e-03 | 16 | 51 | 2 | M27940 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.50e-03 | 137 | 51 | 4 | M145 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.69e-03 | 17 | 51 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.69e-03 | 17 | 51 | 2 | M48025 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.74e-03 | 66 | 51 | 3 | M255 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.06e-03 | 70 | 51 | 3 | M13266 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.11e-03 | 19 | 51 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.11e-03 | 19 | 51 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.34e-03 | 20 | 51 | 2 | M27881 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 2.51e-03 | 75 | 51 | 3 | M641 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.58e-03 | 21 | 51 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.58e-03 | 21 | 51 | 2 | M27485 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.70e-03 | 161 | 51 | 4 | M27871 | |
| Pathway | WP_ESTROGEN_SIGNALING | 2.70e-03 | 77 | 51 | 3 | MM15934 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.83e-03 | 22 | 51 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.83e-03 | 22 | 51 | 2 | MM1443 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 2.91e-03 | 79 | 51 | 3 | M66 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.93e-03 | 272 | 51 | 5 | M29619 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 3.01e-03 | 80 | 51 | 3 | M223 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.09e-03 | 23 | 51 | 2 | M2821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 3.09e-03 | 23 | 51 | 2 | M47537 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 3.23e-03 | 82 | 51 | 3 | M2 | |
| Pathway | PID_REG_GR_PATHWAY | 3.23e-03 | 82 | 51 | 3 | M115 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.37e-03 | 24 | 51 | 2 | M13404 | |
| Pathway | PID_CMYB_PATHWAY | 3.46e-03 | 84 | 51 | 3 | M195 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.65e-03 | 25 | 51 | 2 | MM15713 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.65e-03 | 25 | 51 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.95e-03 | 26 | 51 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 3.95e-03 | 26 | 51 | 2 | M32 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.95e-03 | 26 | 51 | 2 | MM14793 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 4.25e-03 | 27 | 51 | 2 | M26943 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.25e-03 | 27 | 51 | 2 | M47518 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 4.57e-03 | 28 | 51 | 2 | M48253 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 4.57e-03 | 28 | 51 | 2 | M27254 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 4.60e-03 | 93 | 51 | 3 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 4.74e-03 | 94 | 51 | 3 | M41818 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.74e-03 | 94 | 51 | 3 | M1041 | |
| Pubmed | NCOA2 YTHDF1 TCF4 KMT2D SMG7 PNN SCAF8 PRRC2C ATF7IP LIN54 AUTS2 HELZ ZFHX3 GIGYF1 TAF4 MLLT10 RFX7 CREBBP MNT TFAP4 EP300 YTHDF3 PRRC2B | 6.18e-15 | 1429 | 72 | 23 | 35140242 | |
| Pubmed | NCOA2 FLNA KMT2D TOX4 SMG7 PNN PRRC2C CIZ1 TAF4 HUWE1 ARHGAP35 CREBBP CCNK EP300 CSTF2T PRRC2B | 2.18e-14 | 549 | 72 | 16 | 38280479 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 YTHDF1 CRTC3 KMT2D SMG7 SCAF8 PRRC2C AUTS2 HELZ GIGYF1 CREBBP EP300 YTHDF3 PRRC2B | 5.60e-13 | 457 | 72 | 14 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 KMT2D LIN54 AUTS2 ZFHX3 TAF4 RFX7 CREBBP TFAP4 EP300 YTHDF3 PRRC2B | 8.26e-12 | 351 | 72 | 12 | 38297188 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 SMG7 DROSHA PRRC2C ATF7IP LIN54 MED25 HELZ GNAS HUWE1 WNK1 CREBBP YTHDF3 PRRC2B | 1.63e-11 | 588 | 72 | 14 | 38580884 |
| Pubmed | 3.08e-11 | 152 | 72 | 9 | 38360978 | ||
| Pubmed | FLNA CRTC3 TOX4 ATF7IP ADNP2 HELZ SYNPO SEC31A WNK1 CREBBP EP300 | 4.98e-09 | 486 | 72 | 11 | 20936779 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 17410209 | ||
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 1.66e-08 | 14 | 72 | 4 | 15333839 | |
| Pubmed | 3.20e-08 | 335 | 72 | 9 | 15741177 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 28398509 | ||
| Pubmed | ARHGAP5 FLNA EGLN2 KMT2D TOX4 DROSHA ATF7IP FAM161B HUWE1 PCDH1 CREBBP | 3.68e-08 | 591 | 72 | 11 | 15231748 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 POU6F2 SMG7 SCAF8 MYRIP AUTS2 ZFHX3 SYNPO TAF4 GNAS HUWE1 ARHGAP35 PCDH1 CREBBP TFAP4 EP300 | 5.01e-08 | 1489 | 72 | 16 | 28611215 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA TOX4 SMG7 PNN PRRC2C ATF7IP CIZ1 HELZ ARHGAP35 WNK1 DHX29 CCNK PRRC2B | 5.71e-08 | 934 | 72 | 13 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA KMT2D PNN SCAF8 HELZ HUWE1 ARHGAP35 RFX7 DHX29 CCNK TFAP4 CSTF2T | 6.14e-08 | 774 | 72 | 12 | 15302935 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.39e-07 | 398 | 72 | 9 | 35016035 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15731352 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 26123998 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.96e-07 | 7 | 72 | 3 | 9590696 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX11 TCF4 POU6F2 KMT2D TOX4 BARHL2 ADNP2 ZFHX3 RFX7 ZNF282 MNT TFAP4 | 3.40e-07 | 908 | 72 | 12 | 19274049 |
| Pubmed | NCOA2 FLNA KMT2D PRRC2C LIN54 TAF4 CREBBP CCNK MNT TFAP4 EP300 CSTF2T PRRC2B | 3.83e-07 | 1103 | 72 | 13 | 34189442 | |
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 10490106 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | YTHDF1 FLNA TOX4 PNN SNAP91 PRRC2C ATF7IP LIN54 CIZ1 TAF4 CCNK YTHDF3 | 5.74e-07 | 954 | 72 | 12 | 36373674 |
| Pubmed | 8.45e-07 | 83 | 72 | 5 | 28794006 | ||
| Pubmed | 1.43e-06 | 268 | 72 | 7 | 33640491 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 TCF4 KMT2D PRRC2C LIN54 CHSY3 HUWE1 CREBBP MNT TFAP4 EP300 | 1.47e-06 | 857 | 72 | 11 | 25609649 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | YTHDF1 FLNA SMG7 PRRC2C HELZ SEC31A ARHGAP35 DHX29 YTHDF3 PRRC2B | 2.41e-06 | 724 | 72 | 10 | 36232890 |
| Pubmed | 2.49e-06 | 418 | 72 | 8 | 34709266 | ||
| Pubmed | TRIM66 SMG7 DROSHA CIZ1 ADNP2 HELZ ZFHX3 GIGYF1 TAF4 CREBBP EP300 PRRC2B | 2.93e-06 | 1116 | 72 | 12 | 31753913 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | NCOA2 YTHDF1 FLNA PNN ATF7IP AUTS2 HELZ GNAS CSTF2T SEC23A YTHDF3 | 2.96e-06 | 922 | 72 | 11 | 27609421 |
| Pubmed | 2.98e-06 | 107 | 72 | 5 | 30995489 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 3.05e-06 | 14 | 72 | 3 | 17641689 | |
| Pubmed | 3.05e-06 | 14 | 72 | 3 | 12482968 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.16e-06 | 203 | 72 | 6 | 22083510 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.23e-06 | 2 | 72 | 2 | 34845315 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28106076 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19729597 | ||
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 4.23e-06 | 2 | 72 | 2 | 39081030 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15860545 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.23e-06 | 2 | 72 | 2 | 24551300 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 33911074 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9018065 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24648406 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30135524 | ||
| Pubmed | RhoA is down-regulated at cell-cell contacts via p190RhoGAP-B in response to tensional homeostasis. | 4.23e-06 | 2 | 72 | 2 | 23552690 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.23e-06 | 2 | 72 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.23e-06 | 2 | 72 | 2 | 29217654 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20717166 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.23e-06 | 2 | 72 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.23e-06 | 2 | 72 | 2 | 29170789 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 25893291 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 11559821 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.23e-06 | 2 | 72 | 2 | 12646247 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23768074 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 32576962 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19822209 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24522976 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.23e-06 | 2 | 72 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.23e-06 | 2 | 72 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.23e-06 | 2 | 72 | 2 | 34813504 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.23e-06 | 2 | 72 | 2 | 12696060 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.23e-06 | 2 | 72 | 2 | 36109165 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24639469 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 37816914 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.23e-06 | 2 | 72 | 2 | 11438528 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 10918613 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31182547 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 36178483 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 35502657 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30635043 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.23e-06 | 2 | 72 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.23e-06 | 2 | 72 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.23e-06 | 2 | 72 | 2 | 27881443 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19272189 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.23e-06 | 2 | 72 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.23e-06 | 2 | 72 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.23e-06 | 2 | 72 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.23e-06 | 2 | 72 | 2 | 32690000 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9733868 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30953353 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21803292 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9811832 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.23e-06 | 2 | 72 | 2 | 33063428 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 4.23e-06 | 2 | 72 | 2 | 27999180 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 34506759 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22177454 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.23e-06 | 2 | 72 | 2 | 39266679 | |
| Interaction | ALG13 interactions | NCOA2 YTHDF1 TRIM66 KMT2D SMG7 SCAF8 PRRC2C HELZ CCNK EP300 YTHDF3 PRRC2B | 1.02e-12 | 183 | 68 | 12 | int:ALG13 |
| Interaction | TLE3 interactions | NCOA2 FLNA TCF4 CRTC3 KMT2D SMG7 SCAF8 AUTS2 HELZ ZFHX3 TAF4 MLLT10 CREBBP EP300 | 2.41e-11 | 376 | 68 | 14 | int:TLE3 |
| Interaction | NUP35 interactions | NCOA2 YTHDF1 CRTC3 KMT2D SMG7 SCAF8 PRRC2C AUTS2 HELZ GIGYF1 CREBBP EP300 YTHDF3 PRRC2B | 1.18e-10 | 424 | 68 | 14 | int:NUP35 |
| Interaction | HNF1B interactions | NCOA2 POU6F2 KMT2D ATF7IP LIN54 ZFHX3 MLLT10 CREBBP EP300 PRRC2B | 7.92e-10 | 190 | 68 | 10 | int:HNF1B |
| Interaction | CPEB4 interactions | 2.64e-09 | 156 | 68 | 9 | int:CPEB4 | |
| Interaction | EYA4 interactions | 8.51e-09 | 243 | 68 | 10 | int:EYA4 | |
| Interaction | SMG7 interactions | NCOA2 YTHDF1 TRIM66 KMT2D SMG7 SCAF8 HELZ MLLT10 CREBBP YTHDF3 PRRC2B | 9.04e-09 | 319 | 68 | 11 | int:SMG7 |
| Interaction | KLF8 interactions | NCOA2 KMT2D PRRC2C ATF7IP LIN54 TAF4 CREBBP MNT EP300 YTHDF3 PRRC2B | 1.24e-08 | 329 | 68 | 11 | int:KLF8 |
| Interaction | FEV interactions | 2.64e-08 | 203 | 68 | 9 | int:FEV | |
| Interaction | CNOT3 interactions | 3.12e-08 | 207 | 68 | 9 | int:CNOT3 | |
| Interaction | CPEB1 interactions | 3.20e-08 | 146 | 68 | 8 | int:CPEB1 | |
| Interaction | YTHDF2 interactions | YTHDF1 SMG7 PRRC2C HELZ GIGYF1 TAF4 HUWE1 CREBBP YTHDF3 PRRC2B | 9.00e-08 | 312 | 68 | 10 | int:YTHDF2 |
| Interaction | TLX1 interactions | 1.31e-07 | 175 | 68 | 8 | int:TLX1 | |
| Interaction | CNOT2 interactions | 1.49e-07 | 178 | 68 | 8 | int:CNOT2 | |
| Interaction | FAM120C interactions | 2.56e-07 | 191 | 68 | 8 | int:FAM120C | |
| Interaction | CSDE1 interactions | 4.60e-07 | 284 | 68 | 9 | int:CSDE1 | |
| Interaction | YAP1 interactions | FLNA CRTC3 KMT2D TOX4 PNN DROSHA PRRC2C CIZ1 TAF4 GNAS HUWE1 ARHGAP35 CREBBP CCNK EP300 CSTF2T | 5.24e-07 | 1095 | 68 | 16 | int:YAP1 |
| Interaction | KLF15 interactions | 5.48e-07 | 290 | 68 | 9 | int:KLF15 | |
| Interaction | ERG interactions | 8.28e-07 | 223 | 68 | 8 | int:ERG | |
| Interaction | CNOT9 interactions | 1.08e-06 | 231 | 68 | 8 | int:CNOT9 | |
| Interaction | KLHL12 interactions | 1.38e-06 | 104 | 68 | 6 | int:KLHL12 | |
| Interaction | RNF214 interactions | 1.38e-06 | 104 | 68 | 6 | int:RNF214 | |
| Interaction | WWTR1 interactions | 1.43e-06 | 422 | 68 | 10 | int:WWTR1 | |
| Interaction | KLF16 interactions | YTHDF1 KMT2D PRRC2C LIN54 TAF4 HUWE1 TFAP4 EP300 YTHDF3 PRRC2B | 1.53e-06 | 425 | 68 | 10 | int:KLF16 |
| Interaction | BMI1 interactions | YTHDF1 SCAF8 DROSHA PRRC2C CIZ1 HELZ SEC31A DHX29 CREBBP EP300 YTHDF3 PRRC2B | 1.84e-06 | 659 | 68 | 12 | int:BMI1 |
| Interaction | PATL1 interactions | 2.21e-06 | 177 | 68 | 7 | int:PATL1 | |
| Interaction | ZFP36 interactions | 2.56e-06 | 181 | 68 | 7 | int:ZFP36 | |
| Interaction | LSM14A interactions | 2.61e-06 | 260 | 68 | 8 | int:LSM14A | |
| Interaction | GCM1 interactions | 3.33e-06 | 68 | 68 | 5 | int:GCM1 | |
| Interaction | SMAP2 interactions | 3.41e-06 | 189 | 68 | 7 | int:SMAP2 | |
| Interaction | KLF5 interactions | 4.20e-06 | 195 | 68 | 7 | int:KLF5 | |
| Interaction | PHIP interactions | 4.49e-06 | 197 | 68 | 7 | int:PHIP | |
| Interaction | TNRC6A interactions | 4.51e-06 | 280 | 68 | 8 | int:TNRC6A | |
| Interaction | PUM1 interactions | 5.41e-06 | 287 | 68 | 8 | int:PUM1 | |
| Interaction | CELF1 interactions | 5.55e-06 | 288 | 68 | 8 | int:CELF1 | |
| Interaction | RBM47 interactions | 5.65e-06 | 204 | 68 | 7 | int:RBM47 | |
| Interaction | DDX6 interactions | YTHDF1 TCF4 POU6F2 SMG7 PRRC2C HELZ GIGYF1 HUWE1 EP300 YTHDF3 | 6.81e-06 | 503 | 68 | 10 | int:DDX6 |
| Interaction | FUBP3 interactions | 6.95e-06 | 297 | 68 | 8 | int:FUBP3 | |
| Interaction | EIF4ENIF1 interactions | 7.48e-06 | 300 | 68 | 8 | int:EIF4ENIF1 | |
| Interaction | ZC3H7A interactions | 7.96e-06 | 215 | 68 | 7 | int:ZC3H7A | |
| Interaction | SP7 interactions | 8.24e-06 | 304 | 68 | 8 | int:SP7 | |
| Interaction | SOX7 interactions | 8.40e-06 | 82 | 68 | 5 | int:SOX7 | |
| Interaction | R3HDM1 interactions | 9.46e-06 | 84 | 68 | 5 | int:R3HDM1 | |
| Interaction | SP3 interactions | 9.46e-06 | 84 | 68 | 5 | int:SP3 | |
| Interaction | DAZL interactions | 9.48e-06 | 145 | 68 | 6 | int:DAZL | |
| Interaction | MEX3B interactions | 9.81e-06 | 222 | 68 | 7 | int:MEX3B | |
| Interaction | SMG6 interactions | 1.00e-05 | 85 | 68 | 5 | int:SMG6 | |
| Interaction | GSC interactions | 1.12e-05 | 87 | 68 | 5 | int:GSC | |
| Interaction | KLF3 interactions | 1.17e-05 | 228 | 68 | 7 | int:KLF3 | |
| Interaction | OTUD4 interactions | 1.46e-05 | 236 | 68 | 7 | int:OTUD4 | |
| Interaction | SOX10 interactions | 1.48e-05 | 92 | 68 | 5 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.48e-05 | 92 | 68 | 5 | int:FOXI1 | |
| Interaction | DYRK1A interactions | TRIM66 EGLN2 KMT2D DROSHA IRS1 HUWE1 RFX7 CREBBP EP300 SEC23A | 1.53e-05 | 552 | 68 | 10 | int:DYRK1A |
| Interaction | PIAS3 interactions | 1.73e-05 | 95 | 68 | 5 | int:PIAS3 | |
| Interaction | SOX5 interactions | 1.78e-05 | 162 | 68 | 6 | int:SOX5 | |
| Interaction | YTHDF3 interactions | 1.91e-05 | 246 | 68 | 7 | int:YTHDF3 | |
| Interaction | NAA40 interactions | FLNA TOX4 SMG7 PNN PRRC2C ATF7IP CIZ1 HELZ ARHGAP35 WNK1 DHX29 CCNK PRRC2B | 2.00e-05 | 978 | 68 | 13 | int:NAA40 |
| Interaction | GARRE1 interactions | 2.12e-05 | 167 | 68 | 6 | int:GARRE1 | |
| Interaction | CEP85 interactions | 2.27e-05 | 169 | 68 | 6 | int:CEP85 | |
| Interaction | AR interactions | NCOA2 FLNA TCF4 KMT2D PNN LIN54 ZFHX3 GNAS HUWE1 CREBBP CCNK EP300 PRRC2B | 2.32e-05 | 992 | 68 | 13 | int:AR |
| Interaction | CRX interactions | 2.34e-05 | 254 | 68 | 7 | int:CRX | |
| Interaction | EGR2 interactions | 2.42e-05 | 171 | 68 | 6 | int:EGR2 | |
| Interaction | POU5F1 interactions | 2.48e-05 | 584 | 68 | 10 | int:POU5F1 | |
| Interaction | HELZ interactions | 2.53e-05 | 257 | 68 | 7 | int:HELZ | |
| Interaction | NEUROG1 interactions | 3.43e-05 | 19 | 68 | 3 | int:NEUROG1 | |
| Interaction | PAX8 interactions | 3.66e-05 | 111 | 68 | 5 | int:PAX8 | |
| Interaction | TPRX2 interactions | 3.81e-05 | 56 | 68 | 4 | int:TPRX2 | |
| Interaction | HNF4A interactions | 3.89e-05 | 275 | 68 | 7 | int:HNF4A | |
| Interaction | FOXM1 interactions | 3.99e-05 | 113 | 68 | 5 | int:FOXM1 | |
| Interaction | BAG2 interactions | NCOA2 TRIM66 PRRC2C CIZ1 HUWE1 ARHGAP35 WNK1 CREBBP EP300 CSTF2T | 4.23e-05 | 622 | 68 | 10 | int:BAG2 |
| Interaction | MEX3A interactions | 4.40e-05 | 384 | 68 | 8 | int:MEX3A | |
| Interaction | MYOD1 interactions | 4.91e-05 | 194 | 68 | 6 | int:MYOD1 | |
| Interaction | CEBPA interactions | NCOA2 FLNA KMT2D PNN PRRC2C LIN54 TAF4 CREBBP CCNK MNT TFAP4 EP300 CSTF2T PRRC2B | 5.82e-05 | 1245 | 68 | 14 | int:CEBPA |
| Interaction | ZCCHC2 interactions | 6.20e-05 | 23 | 68 | 3 | int:ZCCHC2 | |
| Interaction | UBAP2L interactions | 6.46e-05 | 298 | 68 | 7 | int:UBAP2L | |
| Interaction | CTBP1 interactions | 6.51e-05 | 406 | 68 | 8 | int:CTBP1 | |
| Interaction | UNK interactions | 6.74e-05 | 408 | 68 | 8 | int:UNK | |
| Interaction | RBMS1 interactions | 7.04e-05 | 207 | 68 | 6 | int:RBMS1 | |
| Interaction | MARF1 interactions | 7.23e-05 | 128 | 68 | 5 | int:MARF1 | |
| Interaction | TNIP2 interactions | NCOA2 YTHDF1 FLNA PNN ATF7IP AUTS2 HELZ GNAS EP300 CSTF2T SEC23A YTHDF3 | 7.27e-05 | 952 | 68 | 12 | int:TNIP2 |
| Interaction | R3HDM2 interactions | 7.50e-05 | 129 | 68 | 5 | int:R3HDM2 | |
| Interaction | POLR2A interactions | 7.60e-05 | 536 | 68 | 9 | int:POLR2A | |
| Interaction | TDRD3 interactions | 8.03e-05 | 212 | 68 | 6 | int:TDRD3 | |
| Interaction | ETV4 interactions | 8.69e-05 | 69 | 68 | 4 | int:ETV4 | |
| Interaction | EGLN3 interactions | NCOA2 TCF4 EGLN2 CRTC3 SMG7 SCAF8 DROSHA HELZ IRS1 GIGYF1 GNAS CREBBP ZNF282 PRRC2B | 8.96e-05 | 1296 | 68 | 14 | int:EGLN3 |
| Interaction | TOP3B interactions | YTHDF1 FLNA KMT2D SMG7 HELZ IRS1 GNAS HUWE1 MLLT10 ARHGAP35 WNK1 EP300 SEC23A YTHDF3 PRRC2B | 9.13e-05 | 1470 | 68 | 15 | int:TOP3B |
| Interaction | TNRC6C interactions | 1.03e-04 | 138 | 68 | 5 | int:TNRC6C | |
| Interaction | CHAF1A interactions | 1.05e-04 | 322 | 68 | 7 | int:CHAF1A | |
| Interaction | MAML1 interactions | 1.08e-04 | 73 | 68 | 4 | int:MAML1 | |
| Interaction | CNOT7 interactions | 1.10e-04 | 140 | 68 | 5 | int:CNOT7 | |
| Interaction | ANKRD17 interactions | 1.14e-04 | 226 | 68 | 6 | int:ANKRD17 | |
| Interaction | SMC5 interactions | YTHDF1 FLNA TOX4 PNN SNAP91 PRRC2C ATF7IP LIN54 CIZ1 TAF4 CCNK YTHDF3 | 1.16e-04 | 1000 | 68 | 12 | int:SMC5 |
| Interaction | TLE5 interactions | 1.19e-04 | 443 | 68 | 8 | int:TLE5 | |
| Interaction | ZYX interactions | 1.20e-04 | 329 | 68 | 7 | int:ZYX | |
| Interaction | PUM2 interactions | 1.26e-04 | 144 | 68 | 5 | int:PUM2 | |
| Interaction | FBXO38 interactions | 1.30e-04 | 145 | 68 | 5 | int:FBXO38 | |
| Interaction | NCOA6 interactions | 1.30e-04 | 145 | 68 | 5 | int:NCOA6 | |
| Interaction | HNF1A interactions | 1.55e-04 | 80 | 68 | 4 | int:HNF1A | |
| Interaction | NEUROD1 interactions | 1.70e-04 | 32 | 68 | 3 | int:NEUROD1 | |
| Interaction | CREBBP interactions | 1.76e-04 | 599 | 68 | 9 | int:CREBBP | |
| Cytoband | 4q21.22 | 3.25e-04 | 17 | 72 | 2 | 4q21.22 | |
| Cytoband | 14q21.1 | 4.08e-04 | 19 | 72 | 2 | 14q21.1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.20e-06 | 17 | 41 | 3 | 486 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.10e-04 | 110 | 41 | 4 | 420 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.17e-04 | 15 | 41 | 2 | 529 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.50e-04 | 18 | 41 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 1.11e-03 | 90 | 41 | 3 | 88 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 5.74e-03 | 50 | 41 | 2 | 721 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 4.59e-09 | 141 | 71 | 8 | M7720 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF5 SOX11 CACNA1E SNAP91 LIN54 SLITRK5 ITGA8 AUTS2 ZFHX3 CHSY3 GIGYF1 ARHGAP35 RFX7 PCDH1 PRRC2B | 2.17e-07 | 1106 | 71 | 15 | M39071 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.12e-07 | 467 | 71 | 10 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 7.08e-07 | 484 | 71 | 10 | MM999 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 3.50e-06 | 85 | 71 | 5 | M41085 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLNA KMT2D PNN SCAF8 ATF7IP AUTS2 HELZ GNAS HUWE1 ARHGAP35 RFX7 WNK1 CREBBP EP300 PRRC2B | 8.89e-06 | 1492 | 71 | 15 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 9.54e-06 | 180 | 71 | 6 | M8239 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 1.46e-05 | 194 | 71 | 6 | M3321 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 SCAF8 PRRC2C HELZ ZFHX3 IRS1 TAF4 ARHGAP35 CREBBP MNT YTHDF3 | 1.81e-05 | 856 | 71 | 11 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | 7.36e-05 | 513 | 71 | 8 | M39069 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 8.91e-05 | 166 | 71 | 5 | M7722 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 9.05e-05 | 269 | 71 | 6 | M41203 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 9.17e-05 | 167 | 71 | 5 | M2995 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_DN | 1.75e-04 | 40 | 71 | 3 | M2169 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.79e-04 | 584 | 71 | 8 | M39068 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP | 1.94e-04 | 196 | 71 | 5 | M6293 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 1.94e-04 | 196 | 71 | 5 | M8503 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_DN | 1.99e-04 | 197 | 71 | 5 | M5462 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP | 2.08e-04 | 199 | 71 | 5 | M5009 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 2.13e-04 | 200 | 71 | 5 | M5081 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 2.13e-04 | 200 | 71 | 5 | M9439 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP | 2.13e-04 | 200 | 71 | 5 | M4024 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.44e-04 | 206 | 71 | 5 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.55e-04 | 208 | 71 | 5 | MM581 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 2.72e-04 | 115 | 71 | 4 | M7995 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.06e-07 | 200 | 71 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-07 | 200 | 71 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 176 | 71 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 182 | 71 | 5 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 71 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 71 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 188 | 71 | 5 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.39e-05 | 192 | 71 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 195 | 71 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.58e-05 | 197 | 71 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 198 | 71 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 198 | 71 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 199 | 71 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.69e-05 | 200 | 71 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-05 | 200 | 71 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.40e-05 | 129 | 71 | 4 | 003a3202053986c2eb10d5e84b90ab33b7ee37e3 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.97e-05 | 147 | 71 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 157 | 71 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 160 | 71 | 4 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 161 | 71 | 4 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 162 | 71 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 162 | 71 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 162 | 71 | 4 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 162 | 71 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.30e-04 | 162 | 71 | 4 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 167 | 71 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 169 | 71 | 4 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 169 | 71 | 4 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 169 | 71 | 4 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-04 | 170 | 71 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 183 | 71 | 4 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 184 | 71 | 4 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 186 | 71 | 4 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.21e-04 | 186 | 71 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-04 | 188 | 71 | 4 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.31e-04 | 188 | 71 | 4 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 189 | 71 | 4 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 189 | 71 | 4 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 189 | 71 | 4 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.35e-04 | 189 | 71 | 4 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 189 | 71 | 4 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.40e-04 | 190 | 71 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 190 | 71 | 4 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.40e-04 | 190 | 71 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.45e-04 | 191 | 71 | 4 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 191 | 71 | 4 | cb75e6c36dbe2e091e407d691c063ec7c4fd5f90 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 191 | 71 | 4 | b2cffea7860dd590b505ee0ebd51aa1978cb5e64 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.50e-04 | 192 | 71 | 4 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | e5117cdb8af220f60bd1410262078c0306667b4a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 193 | 71 | 4 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 193 | 71 | 4 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 194 | 71 | 4 | 3bff2e4eb16719ab7419b2f94c9c6e7302aa6629 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 194 | 71 | 4 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 194 | 71 | 4 | fdaf61cbe7f77ff5358d150b38adb1fe3778e961 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-04 | 195 | 71 | 4 | 6e875c83f838241b5fcaf4a3249b1408d74521dc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 195 | 71 | 4 | 4d63e0dca30ae57960459d2fbcba09122273e37b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 195 | 71 | 4 | 661af601a3561fe3aacf2444ad7b8927fa88b48a | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.70e-04 | 196 | 71 | 4 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-04 | 196 | 71 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-04 | 196 | 71 | 4 | c57a95f8b4d8d6334f269d3c16246684f4222a3e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 196 | 71 | 4 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-04 | 197 | 71 | 4 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 198 | 71 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.81e-04 | 198 | 71 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-04 | 198 | 71 | 4 | 076c862f2a723f0361749377561cae902068b1a0 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 198 | 71 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 198 | 71 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.86e-04 | 199 | 71 | 4 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.86e-04 | 199 | 71 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-04 | 200 | 71 | 4 | fc802dd73f048881d9ddafd1b79ab3ca654510e2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-04 | 200 | 71 | 4 | cffddb39960cd611428397c1ec4023192e8af5a7 | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-04 | 200 | 71 | 4 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.92e-04 | 200 | 71 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.92e-04 | 200 | 71 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-04 | 200 | 71 | 4 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-04 | 200 | 71 | 4 | e60aebd20be8012fa2febf6585ed34ebd64ec9b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.92e-04 | 200 | 71 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.92e-04 | 200 | 71 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-04 | 200 | 71 | 4 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.92e-04 | 200 | 71 | 4 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Nnat_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.63e-04 | 87 | 71 | 3 | 7518ca56d626619d9706505169a85f1850105608 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.73e-06 | 184 | 71 | 7 | 2321_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 2.45e-06 | 194 | 71 | 7 | 4612_DN | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.91e-06 | 199 | 71 | 7 | 4775_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.52e-05 | 170 | 71 | 6 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.62e-05 | 172 | 71 | 6 | 1072_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.79e-05 | 175 | 71 | 6 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.91e-05 | 177 | 71 | 6 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.91e-05 | 177 | 71 | 6 | 3227_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.24e-05 | 182 | 71 | 6 | 3887_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 3811_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 4650_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 4341_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 4662_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 5109_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 1301_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 4238_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 5833_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 1843_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 1282_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4829_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 2307_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 3357_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 6963_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 3615_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 2224_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 5782_DN | |
| Drug | MF101 extract | 9.53e-05 | 5 | 71 | 2 | ctd:C517398 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 9.53e-05 | 5 | 71 | 2 | ctd:C575894 | |
| Drug | niobium oxide | 9.53e-05 | 5 | 71 | 2 | CID000123105 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.81e-04 | 168 | 71 | 5 | 3868_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.81e-04 | 168 | 71 | 5 | 3395_DN | |
| Drug | 3'-dCTP | 1.81e-04 | 90 | 71 | 4 | CID000153054 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.97e-04 | 171 | 71 | 5 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-04 | 172 | 71 | 5 | 2330_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.08e-04 | 173 | 71 | 5 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.08e-04 | 173 | 71 | 5 | 3243_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.13e-04 | 174 | 71 | 5 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.13e-04 | 174 | 71 | 5 | 5693_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.19e-04 | 175 | 71 | 5 | 1014_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.19e-04 | 175 | 71 | 5 | 3787_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.25e-04 | 176 | 71 | 5 | 7499_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.25e-04 | 176 | 71 | 5 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.25e-04 | 176 | 71 | 5 | 981_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.31e-04 | 177 | 71 | 5 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.31e-04 | 177 | 71 | 5 | 5308_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.37e-04 | 178 | 71 | 5 | 7245_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.37e-04 | 178 | 71 | 5 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.49e-04 | 180 | 71 | 5 | 5511_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.49e-04 | 180 | 71 | 5 | 4541_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.56e-04 | 181 | 71 | 5 | 6951_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 2.62e-04 | 182 | 71 | 5 | 6896_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.76e-04 | 184 | 71 | 5 | 6939_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.83e-04 | 185 | 71 | 5 | 1673_DN | |
| Drug | trichloramine | 2.85e-04 | 41 | 71 | 3 | CID000061437 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.97e-04 | 187 | 71 | 5 | 4323_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.20e-04 | 190 | 71 | 5 | 4322_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 3.20e-04 | 190 | 71 | 5 | 5237_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 4279_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 6020_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 3665_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 5058_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 4104_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 3753_DN | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 1829_UP | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 2049_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 4343_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 6625_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 4322_UP | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6756_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 5316_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 7137_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 4272_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 3774_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2942_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 3732_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2260_UP | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2468_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2708_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4596_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5863_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6591_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5724_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6309_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6559_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 2847_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4833_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 7496_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.69e-04 | 196 | 71 | 5 | 1021_DN | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 2056_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4443_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 2331_UP | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4600_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 2128_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 1151_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A | 3.78e-04 | 197 | 71 | 5 | 460_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 3899_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6611_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 7217_UP | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6402_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 1828_DN | |
| Disease | Menke-Hennekam syndrome | 5.08e-06 | 2 | 67 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.08e-06 | 2 | 67 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 5.08e-06 | 2 | 67 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.08e-06 | 2 | 67 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.08e-06 | 2 | 67 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.08e-06 | 2 | 67 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.08e-06 | 2 | 67 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 5.08e-06 | 2 | 67 | 2 | C0035934 | |
| Disease | Diffuse Large B-Cell Lymphoma | 7.59e-06 | 55 | 67 | 4 | C0079744 | |
| Disease | Phyllodes Tumor | 5.06e-05 | 5 | 67 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 5.06e-05 | 5 | 67 | 2 | C0600066 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 7.18e-05 | 97 | 67 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | cognitive function measurement | NCOA2 CACNA1E TCF4 POU6F2 KMT2D PRRC2C ATF7IP BARHL2 AUTS2 SERPING1 FAM161B PCDH1 | 8.30e-05 | 1434 | 67 | 12 | EFO_0008354 |
| Disease | body fat percentage | 1.20e-04 | 488 | 67 | 7 | EFO_0007800 | |
| Disease | Endogenous depression | 1.58e-04 | 46 | 67 | 3 | C0011573 | |
| Disease | cortical thickness | NCOA2 CELF5 SOX11 TCF4 SMG7 SNAP91 AUTS2 MLLT10 ARHGAP35 TFAP4 | 1.97e-04 | 1113 | 67 | 10 | EFO_0004840 |
| Disease | lifestyle measurement | 1.98e-04 | 235 | 67 | 5 | EFO_0010724 | |
| Disease | Pseudohypoaldosteronism | 2.26e-04 | 10 | 67 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.26e-04 | 10 | 67 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I | 2.26e-04 | 10 | 67 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.26e-04 | 10 | 67 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.26e-04 | 10 | 67 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.26e-04 | 10 | 67 | 2 | C1449842 | |
| Disease | taste liking measurement | 2.52e-04 | 388 | 67 | 6 | EFO_0010155 | |
| Disease | feeling emotionally hurt measurement | 2.85e-04 | 56 | 67 | 3 | EFO_0009599 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.00e-04 | 257 | 67 | 5 | DOID:10652 (is_marker_for) | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 4.54e-04 | 14 | 67 | 2 | DOID:898 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 4.62e-04 | 66 | 67 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 4.91e-04 | 616 | 67 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.91e-04 | 616 | 67 | 7 | C0376358 | |
| Disease | Lymphoma, Large-Cell, Follicular | 5.23e-04 | 15 | 67 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 5.23e-04 | 15 | 67 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 5.23e-04 | 15 | 67 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 5.23e-04 | 15 | 67 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 5.23e-04 | 15 | 67 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 5.23e-04 | 15 | 67 | 2 | C1956130 | |
| Disease | T-Cell Lymphoma | 5.97e-04 | 16 | 67 | 2 | C0079772 | |
| Disease | household income | 6.44e-04 | 304 | 67 | 5 | EFO_0009695 | |
| Disease | intellectual disability (implicated_via_orthology) | 6.72e-04 | 75 | 67 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | reaction time measurement | 7.25e-04 | 658 | 67 | 7 | EFO_0008393 | |
| Disease | urinary albumin to creatinine ratio | 7.45e-04 | 179 | 67 | 4 | EFO_0007778 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 9.35e-04 | 84 | 67 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Lymphoma, Follicular | 9.40e-04 | 20 | 67 | 2 | C0024301 | |
| Disease | information processing speed | 9.67e-04 | 85 | 67 | 3 | EFO_0004363 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.02e-03 | 195 | 67 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.04e-03 | 21 | 67 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | smoking behavior | 1.08e-03 | 341 | 67 | 5 | EFO_0004318 | |
| Disease | grip strength measurement | 1.21e-03 | 350 | 67 | 5 | EFO_0006941 | |
| Disease | Obesity | 1.23e-03 | 205 | 67 | 4 | C0028754 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.25e-03 | 23 | 67 | 2 | C1708353 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.25e-03 | 206 | 67 | 4 | C0152013 | |
| Disease | Squamous cell carcinoma of esophagus | 1.33e-03 | 95 | 67 | 3 | C0279626 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.43e-03 | 364 | 67 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | obesity (implicated_via_orthology) | 1.47e-03 | 215 | 67 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.55e-03 | 100 | 67 | 3 | C0010606 | |
| Disease | risk-taking behaviour | 1.72e-03 | 764 | 67 | 7 | EFO_0008579 | |
| Disease | Sezary Syndrome | 1.72e-03 | 27 | 67 | 2 | C0036920 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.80e-03 | 566 | 67 | 6 | EFO_0007660, EFO_0008354 | |
| Disease | alcohol consumption measurement | 1.92e-03 | 1242 | 67 | 9 | EFO_0007878 | |
| Disease | suicidal ideation | 1.98e-03 | 29 | 67 | 2 | EFO_0004320 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQLRQTQGLPLPQPL | 426 | P84996 | |
| TQLPQQVQPSLPAAP | 891 | Q09472 | |
| QNPGPLIPQPSSQQT | 651 | Q9NQ75 | |
| NPLNPLNPLSSLNPL | 806 | Q15878 | |
| HQLQQPPSLQPTPQV | 271 | O75909 | |
| PQTQLQPQVPGQQPA | 496 | Q92793 | |
| SPSPVTPAQNNLLQP | 681 | O60641 | |
| QSPQIQATISPPLQP | 191 | Q7Z478 | |
| GQNSLTLQPPAPQPV | 341 | Q6IQ32 | |
| TPLPQIQPNLTNLPP | 441 | Q6MZP7 | |
| LLQQQQAVPVPPAPS | 741 | O75420 | |
| SLLPNQVPVPQLPVQ | 466 | P15884 | |
| EPVAQPQPQSQPQLQ | 471 | Q9H307 | |
| SNSPLPSIQLQPQSP | 971 | Q08174 | |
| GQVDPLQLQTPPQTQ | 106 | A1E959 | |
| QVAQPIPQPQTEPQL | 301 | Q8WXX7 | |
| PEAQLQPAPQPQVQR | 346 | Q8WXX7 | |
| LPPAHLPVQQQQPQQ | 391 | Q99583 | |
| LPVQQQQPQQKTPLP | 396 | Q99583 | |
| NNLPSNIPRPQTQPP | 136 | Q96MY7 | |
| NLLQLRPPQPQPQGT | 581 | Q71SY5 | |
| PQSEQPQQPQARPVL | 51 | P06850 | |
| EQQQQQQPLLHPPEP | 876 | P35568 | |
| PQELPPGLPNNINIT | 26 | Q02509 | |
| SQLNQQPQQPPPQLS | 1406 | P42694 | |
| QSSQQQPTLPTPPAL | 2766 | Q7Z6Z7 | |
| TLGPLQCQPNPNINP | 861 | P53708 | |
| QPPATIIQQLPQQPL | 206 | P58505 | |
| PSVQPPLRSQQLAPQ | 1746 | P21333 | |
| PQELTQPLLQQPRAP | 451 | Q6UUV7 | |
| SVPQPPPLLQQQQRE | 381 | Q8N6W0 | |
| PTQSLQPLPQQQQPL | 101 | Q9NY43 | |
| TQPTIQPTQPTTQLP | 96 | P05155 | |
| QVPSGNPQPTISLQP | 766 | Q6VMQ6 | |
| NPQPTISLQPLPVIL | 771 | Q6VMQ6 | |
| QQPLQPIQPPQNLSV | 341 | P20794 | |
| NLCRTPQLIIPNQNP | 201 | Q6UWM5 | |
| PQLIIPNQNPFLKPT | 206 | Q6UWM5 | |
| TPLQPQPQQTLATEP | 21 | P55289 | |
| NVLLNQQNPPAPQPQ | 226 | Q9H0L4 | |
| QPQPLSQALPQLPGS | 6 | Q96KS0 | |
| QNLPPLSIPNQRMPT | 906 | Q9UPN6 | |
| MLTTPQQIQLNPLQP | 776 | O00268 | |
| PHQQLLQPPGQQPSQ | 251 | P35716 | |
| PQNLRLLHPQQPPVQ | 36 | Q9NRR4 | |
| NQNPPATVVPQSLPL | 341 | Q8N3V7 | |
| QPAPQAPSQSQQQPL | 206 | P78424 | |
| PAPTSQLQQAPQPQQ | 236 | P78424 | |
| SPLTPPNPLQLVNNP | 286 | P78424 | |
| LQPLLSGLQPQPPEQ | 776 | Q96ME1 | |
| QGPQQSQPPSQQPLT | 731 | Q92540 | |
| TLVNNVPLPNTLPLP | 2211 | Q9Y520 | |
| QPLIALPQTLQPPLQ | 2601 | Q9Y520 | |
| LPQTLQPPLQHTTPQ | 2606 | Q9Y520 | |
| QPQLIQPQLQTDPLG | 1486 | Q13017 | |
| PQSPMQPLLPSQLQA | 1481 | Q9NRY4 | |
| LTQATRGPQVQQPPP | 211 | Q15436 | |
| PELQQLQIPGPTQIP | 1006 | P55197 | |
| LQIPGPTQIPINNLL | 1011 | P55197 | |
| QPLPQPQSRPRQEQS | 61 | Q70JA7 | |
| LQLQQLLQQSPPQAP | 36 | Q9ULV3 | |
| SRGLPPQQPQQPLLN | 56 | Q9ULV3 | |
| NLQNSPVNMNPPPLS | 561 | Q15596 | |
| TQPVLPPQTIIQQPQ | 291 | Q7Z739 | |
| QQQPPPQLQLQPGEE | 806 | O94991 | |
| QIQASPLQTSQPTPP | 41 | A6NJ88 | |
| GQQPLILPQSIQLPP | 2086 | Q5JSZ5 | |
| NLPNGNPSILSPQPI | 246 | Q2KHR2 | |
| QLQQQQLQPPPLEPE | 301 | P0CG23 | |
| AQPVSQPQAPQVLPQ | 771 | Q9H4A3 | |
| TGQPLPPLQIPQQTA | 361 | O94979 | |
| LSHFQQQPQQQLPPP | 446 | O15016 | |
| QQQLRTQLLPPPAPT | 216 | Q01664 | |
| TILQQPPPLQAMQQP | 461 | O94842 | |
| LSGPPLQLQQTPPLQ | 251 | A6NL46 | |
| LQSQPQPQSLPPIAV | 421 | Q9UDV7 | |
| APLQPALQLAPQQPQ | 126 | Q6PEX7 | |
| SPQAAPQPQQVAQPL | 291 | Q9BYJ9 | |
| TPQQLANLPPQLIPY | 2516 | Q15911 | |
| SPIQTPNQTPQQAPV | 11 | Q8IZS6 | |
| LLVQPQPQPQPSSLQ | 4076 | O14686 | |
| QPQPQPSSLQLQPPL | 4081 | O14686 | |
| LTLNNQPPPGNRSQP | 66 | P20592 | |
| ALPRNPQPQPTQAQS | 416 | Q8NFW9 |